Edison Oncology - Crunchbase Company Profile & Funding

Overview

Edison Oncology

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Edison Oncology

CB Rank

329553

Edison Oncology develops and commercializes new therapies for cancer patients and their families.

Founded

obfuscation

Private

Menlo Park, California, United States

1-10

www.edisononcology.com

Biotechnology

Health Care

Oncology

Therapeutics

Details

Legal Name

Edison Oncology Holding Corp.

Operating Status

Active

Company Type

For Profit

Founders

Jeffrey Bacha

About the Company

Edison Oncology develops and commercializes new therapies for cancer patients and their families. The company was founded in 2018 by Jeffrey Bacha and is headquartered in Menlo Park, California, United States.

Phone Number

650-690-1927

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Orotecan® (irinotecan HCl oral solution)

An oral formulation of irinotecan designed for treating recurrent pediatric solid tumors by improving drug delivery and patient compliance.

EO1001 (irreversible pan-ErbB inhibitor)

A small-molecule inhibitor targeting the ErbB family of receptors with brain penetration, developed for treating advanced cancers including brain metastases.